Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first1,041 to 1,060 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| CD55 CD55 molecule (Cromer blood group) | 1604 HGNC:2665 | 1 | 198 | 0 | 0 | 3,346 | 6,883 |
| GCK glucokinase | 2645 HGNC:4195 | 1 | 44 | 7 | 57 | 3,487 | 6,883 |
| IFNA8 interferon alpha 8 | 3445 HGNC:5429 | 1 | 97 | 2 | 10 | 4,093 | 6,880 |
| XPO1 exportin 1 | 7514 HGNC:12825 | 1 | 56 | 1 | 176 | 3,721 | 6,862 |
| CHI3L1 chitinase 3 like 1 | 1116 HGNC:1932 | 1 | 102 | 0 | 0 | 3,301 | 6,844 |
| UGT1A1 UDP glucuronosyltransferase family 1 member A1 | 54658 HGNC:12530 | 1 | 70 | 0 | 0 | 2,552 | 6,827 |
| RPTOR regulatory associated protein of MTOR complex 1 | 57521 HGNC:30287 | 1 | 25 | 1 | 11 | 4,724 | 6,826 |
| CPT1A carnitine palmitoyltransferase 1A | 1374 HGNC:2328 | 1 | 81 | 0 | 0 | 3,670 | 6,821 |
| STAT4 signal transducer and activator of transcription 4 | 6775 HGNC:11365 | 1 | 67 | 0 | 0 | 4,110 | 6,821 |
| CCR1 C-C motif chemokine receptor 1 | 1230 HGNC:1602 | 1 | 168 | 3 | 4 | 3,914 | 6,819 |
| H1-5 H1.5 linker histone, cluster member | 3009 HGNC:4719 | 1 | 33 | 0 | 0 | 1,278 | 6,815 |
| GABARAP GABA type A receptor-associated protein | 11337 HGNC:4067 | 1 | 36 | 0 | 0 | 4,274 | 6,804 |
| BAP1 BRCA1 associated deubiquitinase 1 | 8314 HGNC:950 | 1 | 33 | 0 | 0 | 2,209 | 6,800 |
| NEAT1 nuclear paraspeckle assembly transcript 1 | 283131 HGNC:30815 | 0 | 0 | 0 | 0 | 2,056 | 6,777 |
| MKI67 marker of proliferation Ki-67 | 4288 HGNC:7107 | 1 | 55 | 0 | 0 | 4,107 | 6,766 |
| PTPN1 protein tyrosine phosphatase non-receptor type 1 | 5770 HGNC:9642 | 1 | 92 | 0 | 0 | 2,932 | 6,766 |
| IAPP islet amyloid polypeptide | 3375 HGNC:5329 | 1 | 149 | 0 | 0 | 2,800 | 6,754 |
| RAB5A RAB5A, member RAS oncogene family | 5868 HGNC:9783 | 1 | 54 | 0 | 0 | 4,442 | 6,746 |
| APOC3 apolipoprotein C3 | 345 HGNC:610 | 1 | 152 | 3 | 19 | 3,067 | 6,745 |
| ST2 suppression of tumorigenicity 2 | 6761 | 0 | 0 | 0 | 0 | 3,251 | 6,745 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=53
{
"data": {
"total": 193990,
"results": [
{
"id": "1604",
"title": "CD55: CD55 molecule (Cromer blood group)",
"summary": "NCBI Gene 1604. 1 protein, 198 patents, 0 drugs, 0 trials, 3,346 NIH grants and 6,883 papers.",
"record": "/library/genes/1604",
"gene_id": 1604,
"symbol": "CD55",
"name": "CD55 molecule (Cromer blood group)",
"hgnc_id": "HGNC:2665",
"counts": {
"proteins": 1,
"patents": 198,
"drugs": 0,
"trials": 0,
"grants": 3346,
"papers": 6883
}
},
{
"id": "2645",
"title": "GCK: glucokinase",
"summary": "NCBI Gene 2645. 1 protein, 44 patents, 7 drugs, 57 trials, 3,487 NIH grants and 6,883 papers.",
"record": "/library/genes/2645",
"gene_id": 2645,
"symbol": "GCK",
"name": "glucokinase",
"hgnc_id": "HGNC:4195",
"counts": {
"proteins": 1,
"patents": 44,
"drugs": 7,
"trials": 57,
"grants": 3487,
"papers": 6883
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=54",
"request_id": "aLZ1ZFO7_PafspMI"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant